Oramed Pharmaceuticals Inc (ORMP) Insider Trading
- $2,904,796.82
- $6,562,971.15
- March 16, 2023
- Nadav Kidron
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 16, 2023 | CEO | 26,000 | $2.04 | Buy | $53,040.00 | |
| March 14, 2023 | CEO | 100,000 | $2.01 | Buy | $201,000.00 | |
| March 13, 2023 | Director | 20,000 | $1.96 | Buy | $39,200.00 | |
| Jan. 3, 2023 | Insider | 13,325 | $12.55 | Sell | $167,228.75 | |
| March 21, 2022 | Director | 10,000 | $9.41 | Sell | $94,100.00 | |
| Sept. 16, 2021 | Director | 21,100 | $20.99 | Sell | $442,889.00 | |
| Aug. 9, 2021 | CEO | 220,000 | $20.11 | Sell | $4,424,200.00 | |
| Sept. 9, 2019 | Director | 25,000 | $2.92 | Buy | $73,000.00 | |
| July 18, 2019 | Director | 4,497 | $3.86 | Buy | $17,358.42 | |
| July 16, 2019 | Director | 20,000 | $3.47 | Buy | $69,400.00 | |
| July 11, 2019 | Director | 1,320 | $3.22 | Buy | $4,250.40 | |
| Aug. 9, 2018 | Director | 2,500 | $4.95 | Buy | $12,375.00 | |
| July 10, 2018 | Insider | 61 | $5.98 | Sell | $364.78 | |
| Aug. 2, 2017 | Director | 89,636 | $8.50 | Buy | $761,906.00 | |
| April 19, 2017 | Insider | 52,814 | $6.33 | Sell | $334,312.62 | |
| May 12, 2016 | CEO | 1,000 | $6.95 | Buy | $6,950.00 | |
| Dec. 30, 2015 | CTO | 50,000 | $8.90 | Sell | $445,000.00 | |
| Dec. 9, 2015 | Director | 700 | $9.44 | Sell | $6,608.00 | |
| Dec. 8, 2015 | Director | 1,300 | $8.70 | Sell | $11,310.00 | |
| March 19, 2015 | CEO | 2,600 | $3.88 | Buy | $10,088.00 | |
| Sept. 11, 2014 | CTO | 31,699 | $8.41 | Sell | $266,588.59 | |
| Sept. 10, 2014 | CTO | 23,000 | $8.40 | Sell | $193,200.00 | |
| Sept. 4, 2014 | CTO | 8,301 | $9.41 | Sell | $78,112.41 | |
| June 6, 2014 | Major Shareholder | 2,252 | $4.44 | Buy | $9,998.88 | |
| March 31, 2014 | Director | 9,434 | $10.50 | Sell | $99,057.00 | |
| March 25, 2014 | major shareholder | 75,000 | $10.62 | Buy | $796,500.00 | |
| Feb. 6, 2014 | major shareholder | 51,292 | $15.61 | Buy | $800,668.12 | |
| July 10, 2013 | Major Shareholder | 6,630 | $7.40 | Buy | $49,062.00 |
Insiders are both buying and selling Oramed Pharmaceuticals Inc stock.
The insider traders at Oramed Pharmaceuticals Inc are: Nadav Kidron, Miriam Kidron, Regals Capital Management Lp, Leonard Sank, Michael Berelowitz, Kevin Rakin, Yadin Rozov, Michael Rabinowitz, Xiaopeng Li, and Aviad Friedman
The most active insider trader at Oramed Pharmaceuticals Inc is Nadav Kidron with 6 trades.
Nadav Kidron has sold the most Oramed Pharmaceuticals Inc stock with a total value of $8,848,764.78.
Regals Capital Management Lp has bought the most Oramed Pharmaceuticals Inc stock with a total value of $1,666,227.88.
The most recent insider trade for Oramed Pharmaceuticals Inc was on March 16, 2023.
The single biggest insider buy for Oramed Pharmaceuticals Inc was from Regals Capital Management Lp with a total value of $800,668.12 on Feb. 6, 2014.
The single biggest insider sell for Oramed Pharmaceuticals Inc was from Nadav Kidron with a total value of $4,424,200.00 on Aug. 9, 2021.